Nextgen Biomed Management
Management criteria checks 2/4
Nextgen Biomed's CEO is Harel Hershtik, appointed in Nov 2022, has a tenure of 2.25 years. total yearly compensation is ₪794.00K, comprised of 49.7% salary and 50.3% bonuses, including company stock and options. directly owns 3.73% of the company’s shares, worth ₪244.92K. The average tenure of the management team and the board of directors is 2.3 years and 2.2 years respectively.
Key information
Harel Hershtik
Chief executive officer
₪794.0k
Total compensation
| CEO salary percentage | 49.7% |
| CEO tenure | 2.3yrs |
| CEO ownership | 3.7% |
| Management average tenure | 2.3yrs |
| Board average tenure | 2.2yrs |
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -₪14m |
| Mar 31 2024 | n/a | n/a | -₪14m |
| Dec 31 2023 | ₪794k | ₪395k | -₪14m |
Compensation vs Market: Harel's total compensation ($USD223.88K) is below average for companies of similar size in the IL market ($USD417.84K).
Compensation vs Earnings: Insufficient data to compare Harel's compensation with company performance.
CEO
Harel Hershtik (49 yo)
2.3yrs
Tenure
₪794,000
Compensation
Mr. Harel Hershtik serves as CEO & GM of Nextgen Biomed Ltd since November 22, 2022.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & GM | 2.3yrs | ₪794.00k | 3.73% ₪ 244.9k | |
| CFO & VP of Finance | 2.1yrs | ₪612.29k | no data | |
| Legal Advisor & Company Secretary | 10.1yrs | ₪195.00k | no data |
2.3yrs
Average Tenure
Experienced Management: NXGN's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board | 4.1yrs | ₪524.00k | 2.78% ₪ 182.2k | |
| Director | 2.3yrs | no data | 1.56% ₪ 102.7k | |
| Director | 2.3yrs | no data | no data | |
| Director | 2.2yrs | no data | no data | |
| Independent Outside Director | 1.5yrs | no data | no data | |
| Independent Outside Director | 1.5yrs | no data | no data |
2.2yrs
Average Tenure
53.5yo
Average Age
Experienced Board: NXGN's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/19 18:29 |
| End of Day Share Price | 2025/02/19 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Nextgen Biomed Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.